medEra Life Science Corp. -- Announcement.

VANCOUVER, British Columbia--(BUSINESS WIRE)--April 30, 1999--

Arn Schoch, VP of Business Development of medEra Life Science Corporation (the "Company") (VSE:MER) (Nasdaq:MEDRF) is pleased to announce that the Company has arranged a private placement, subject to regulatory approval, of 1,000,000 units to various investors at a price of $3.00 per unit to raise $3,000,000.00. Each unit will consist of one common share and one non-transferable share purchase warrant entitling the holder thereof to purchase one additional common share of the Company at a price of $3.50 per share for one year. A finder's fee of 10% of the proceeds will be paid.

The proceeds of the private placement will be used for general working capital.

For additional information, please contact:

Arn Schoch, Vice President, Business Development medEra Life Science Corporation 604/687-7463, ext. 130 or 1-800-663-8068

ON BEHALF OF THE BOARD OF DIRECTORS

Arn Schoch VP, Business Development

This News Release may include certain 'forward-looking statements' within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that may be included in this release, including, without limitation, statements regarding product potential and future plans and objectives of the Company are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. No Stock Exchanges have either approved or disapproved the information contained herein.